Building Biotechnology: Starting, Managing, and Understanding Biotechnology Companies

Commercialization Strategies of Biotechnology Companies

In the biotechnology industry today, there are many business models for project commercialization. These models range from independent vertical integration to certain forms of collaboration with pharmaceutical companies to complete acquisitions of projects by the big pharmaceutical companies. In this thesis, we wanted to study commercialization strategies of several biotechnology companies. We ...

Financing Development Stage Biotechnology Companies: RMs vs

We examine reverse mergers (RMs) in the biotechnology industry and find that, when compared to initial public offerings (IPOs), RMs are smaller, have significantly lower market valuations relative to size, and generally invest less. We also find that RMs exhibit positive abnormal returns on the announcement date and throughout the first year after the RM event. In looking at liquidity measures,...

Biotechnology and Social Aspect

Managing the Analytical Lifecycle for Biotechnology Products

Biotechnology pipelines have demonstrated significant growth over the past decade, with many therapeutic candidates evolving in a single class of protein molecules: the monoclonal antibodies (MAbs). To develop such therapeutic candidates, a scalable drug development process must leverage in-house and industry-wide knowledge so biotechnology companies can address the economic and medical needs o...

Challenging regulations: Managing risks in crop biotechnology

Alongside other aspects of agriculture, plant breeding is pivotal to securing crop yields necessary to meet the growing demands for human food and animal feed. In addition to the important targets of yield, nutritional quality and resilience to abiotic stresses, breeding for resistance to pests and diseases will become even more critical as the availability of plant protection products is furth...